VODEN
VODEN Medical Instruments is an Italy-based medical diagnostics distributor and solutions provider serving hospitals, pharmacies, and research institutions through three divisions: POCT, Pharmacy Self-Analysis, and Life Science, with exclusive Italian distribution rights for premium global diagnostic brands.
- Company typePrivate
- Founded2003
- HeadquartersMeda, Italy
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What VODEN does
VODEN Medical Instruments S.p.A. is an Italian medical diagnostics company founded in 2003, headquartered in Meda (MB), Italy, operating across three divisions: Point-of-Care Testing (POCT), Pharmacy Self-Analysis, and Life Science. The POCT division distributes and supplies portable diagnostic instruments for hospital emergency and critical care settings, including the VCHEMYS clinical chemistry analyzer, OPTI CCA-TS2 portable blood gas analyzer, Nexus IB10 immunoassay platform for cardiac biomarkers, AQUILA blood cell counter, and MISSION PT/INR coagulometer. The Pharmacy division equips Italian pharmacies with self-analysis instruments (VChemy EVO, Vxell, i-CHROMA II, UriDoctor, VCube D, bone densitometry, spirometry) and telecardiology platforms under Italy's 'Farmacia dei Servizi' framework. The Life Science division distributes research tools from premium global partners including Bionano Genomics (Saphyr optical genome mapping), GenDx (immunogenetics and transplant biology), StemCell Technologies (cell culture), UVITEC (imaging), and Sphingotec (novel biomarkers).
The company's business model combines one-time instrument sales with recurring revenue from reagents, consumables, test strips, sensor cassettes, and rotors, supplemented by software licensing (VodenLink, VodenLink PLUS, Vlight) and technical support services delivered through authorized partner Moelca srl. Voden monetizes its customer relationships through a dedicated commercial network with specialized sales personnel for each of its three divisions, covering the entire Italian territory through direct field sales supplemented by active participation in pharmaceutical trade shows (PharmExpo, Cosmofarma, Cosmopharma, PharmaEvolution). The Vxell 4.0 incorporates AI-enhanced HD digital microscopy for blood cell morphology, and the company holds ISO 9001:2015 and ISO 14001:2015 certifications. In March 2025, Eurobio Scientific acquired Voden's life sciences unit, and in 2026 Voden launched Accury (Italy's first decentralized clinical laboratory authorized by Regione Lombardia) and CYD (a drink drug detection test).
VODEN firmographics
Firmographics- Name
- VODEN
- Legal name
- Voden Medical Instruments S.p.A.
- Website
- https://vodenmedical.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- VODEN Medical Instruments is an Italy-based medical diagnostics distributor and solutions provider serving hospitals, pharmacies, and research institutions through three divisions: POCT, Pharmacy Self-Analysis, and Life Science, with exclusive Italian distribution rights for premium global diagnostic brands.
- Ownership category
- akta.pro rank
VODEN industry classification
Industry- Product category
- Point-of-Care Diagnostics
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413), Surgical and Medical Instrument Manufacturing (339112), Medical and Diagnostic Laboratories (62151)
- SIC
- Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Cardiac & Coagulation POCT (Troponin, BNP, INR/aPTT, D-dimer) (HLAHAOAC)
- akta.pro secondary industries
- Hematology POCT (CBC/hemoglobin/hematocrit) (HLAHAOAD), Infectious Disease POCT (Respiratory, STI, HIV, Sepsis) (HLAHAOAA), Molecular POCT / NAAT Systems (PCR/Isothermal platforms & cartridges) (HLAHAOAI), Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), Point-of-Care Testing (POCT) & Near-Patient Labs (HLAFAMAI)
Keywords
Where VODEN is headquartered
LocationHeadquarters
- HQ city
- Meda
- HQ country
- Italy
- HQ region
- Europe
Offices3 records
Markets served
VODEN business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D
Revenue model
- Diagnostic Instrument Sales: Sale of point-of-care diagnostic instruments including clinical chemistry analyzers, blood gas analyzers, hematology counters, immunoassay platforms, and coagulation meters to hospitals, pharmacies, and research institutions.
- Reagent and Consumable Sales: Recurring revenue from sale of reagent kits, test strips, sensor cassettes, rotors, and other consumables required for operation of distributed diagnostic instruments.
- Software Licensing: Licensing of VodenLink management software for POCT data management and VodenLink PLUS/VLight for pharmacy self-analysis management.
- Technical Support and Service: Technical and application support services for installed instruments through authorized service partner Moelca srl.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
VODEN product offering
Product offeringCore offering
VODEN Medical Instruments S.p.A. manufactures and distributes point-of-care diagnostic instruments, reagents, and consumables across three divisions: POCT (hospital point-of-care testing for clinical chemistry, blood gas, hematology, cardiac biomarkers, and coagulation), Pharmacy (self-analysis diagnostic systems for Italian pharmacies under the Farmacia dei Servizi framework), and Life Science (immunogenetics, optical genome mapping, single-cell analysis, and cell biology research tools). The company also licenses the VodenLink software platform for instrument connectivity and LIS/HIS integration.
Product overview
VODEN Medical Instruments S.p.A. is an Italian medical diagnostics company founded in 2003, operating three divisions: POCT (Point of Care Testing), Pharmacy Self-Analysis, and Life Science. The POCT division offers portable analyzers for clinical chemistry (VCHEMYS), blood gas analysis (OPTI CCA-TS2), cardiac biomarkers (Nexus IB10), blood cell counting (AQUILA), and coagulation (MISSION PT/INR). The Pharmacy division provides self-analysis solutions including Samsung Exdia PT10S clinical chemistry, i-CHROMA II immunofluorescence, QBC STAR hematology, UriDoctor urinalysis, VCube D vitamin D testing, bone densitometry, spirometry, and telecardiology via the CardioVoden platform. Supporting platforms include VodenLink for POCT instrument management and VodenLink PLUS/Vlight for pharmacy operations. The Life Science division supplies instruments for immunogenetics (HLA typing), optical genome mapping (Saphyr), single cell analysis (BioSkryb), nucleic acid extraction, cell culture reagents, and electrophoresis imaging (UVITEC). Sub-brands include Accury (decentralized pharmacy laboratory) and CYD (drink drug detection). The company holds ISO 9001:2015 and ISO 14001:2015 certifications.
Differentiator
Problem solved
Functional benefit
Brands
- CYD: Drink safety test product - the world's #1 anti-drug test for drinks. Detects GHB, ketamine, scopolamine, benzodiazepines, cocaine, and other substances commonly used in drink tampering. Available as single-use strips.
- Accury
- Vxell
- VChemy S
- VodenLink
- VCube
Products and services
- VCHEMYS (VChemy S / VChemy EVO) Point-of-care clinical chemistry analyzer using UV/IR absorption spectrometry and turbidimetry with up to 40 independent reading channels; provides up to 24 biochemical parameters from a single capillary blood sample in 12 minutes for hospital and pharmacy use.
- OPTI CCA-TS2 Portable Blood Gas Analyzer Portable laboratory station with optical fluorescence technology, multi-parameter disposable sensor cassettes, and automatic sample aspiration. The only portable blood gas analyzer with direct Hb and SO2 measurement; certified for use on aircraft and rescue vehicles.
- Nexus IB10 Immunoassay Analyzer Point-of-care immunochemical platform for cardiac biomarkers (Troponin I, NT-proBNP), sepsis markers (PCT, D-Dimer), and Sphingotest biomarkers (penKid, Bio-ADM, DPP3) for ICU patient management, delivering results for up to 3 analytes in 20 minutes.
- AQUILA Point-of-Care Blood Cell Counter 3-population point-of-care blood cell counter with dual counting chamber for 22 hematological parameters, featuring all-inclusive reactive packs and optional rechargeable battery for portable use in hospital settings.
- MISSION PT/INR Portable Coagulometer Portable coagulometer for PT/INR self-monitoring in oral anticoagulant therapy, providing results in approximately 2 minutes using fluorescence method.
- DrugControl Drugs of Abuse Tests Rapid immunochromatographic tests for qualitative detection of drugs of abuse in urine, available as single strips or multi-parameter cards detecting up to 9 substances including cocaine, morphine, cannabinoids, and benzodiazepines.
- Vxell 4.0 AI Blood Cell Counter AI-enhanced HD digital microscopy blood cell counter, the first NPT-certified instrument for pharmacy blood counts, delivering 'Lab Grade' morphological cell analysis previously only available in hospital settings.
- Exdia PT10S (Samsung Labgeo) Clinical Chemistry Analyzer Pharmacy self-analysis biochemistry analyzer providing up to 9 results from 70 µl capillary blood sample in 7 minutes, with 22 available tests and multi-parameter profiles, achieving 95% correlation to central laboratory instrumentation.
- i-CHROMA II Selftesting Immunofluorescence System Immunofluorescence instrument for pharmacy self-testing that quantitatively measures CRP, PSA, HCG, TSH, HbA1c, FOB, and MAU in capillary blood with 25-test kit capacity.
- UriDoctor Urinalysis System Automated urinalysis system providing chemical-physical screening, Micro Albumin and Creatinine dosage, and Free Radicals testing with 11-parameter strips in approximately 2 minutes for pharmacy use.
- QBC STAR PST Hematology Analyzer Automated hematology analyzer for pharmacy blood counts from capillary blood with dry reagent technology (no liquid reagents), ISS-certified, providing 3-population WBC differential.
- VCube D Vitamin D Measurement System Vitamin D quantitative measurement system using immunochromatographic strips for capillary blood, providing results in 15 minutes with 10 µl sample volume for pharmacy and preventive health use.
- OSTEO PRO EASY Bone Densitometer Calcaneal ultrasound bone densitometer for osteoporosis screening, providing T-Score and Z-Score measurements in 45 seconds with no radiation and no consumables except gel.
- Vitalograph Alpha Touch Spirometer Bench spirometer with Fleisch-type pneumotach for lung function evaluation, measuring VC, FVC, FEV1, FEV1 Ratio, FEV6, PEF, FEF25-75% with integrated printer for pharmacy and primary-care use.
- DopplexAbility ABI Screening System Automatic Ankle-Brachial Index (ABI) system for peripheral arterial disease and venous insufficiency screening, providing bilateral measurements in 3 minutes with battery and integrated printer.
- CardioVoden Telecardiology Platform Telecardiology platform for ECG at rest, Holter ECG, and Holter Pressure with online reporting through cardio.vodenmedical.com and 24-hour telemedicine reporting response time for pharmacy-based cardiac diagnostics.
- Accury Decentralized Clinical Laboratory Service First decentralized clinical analysis laboratory in Italy authorized by Regione Lombardia, enabling pharmacy-based capillary blood tests with results published directly to the patient's Electronic Health Record within 15 minutes; includes corporate wellness solutions.
- CYD Drink Safety Test Single-drop colorimetric test strips that detect date rape drugs and other controlled substances in beverages within seconds; recognizes 50+ substances including GHB, ketamine, scopolamine, benzodiazepines, and cocaine.
- Saphyr Optical Genome Mapping System Optical genome mapping platform by Bionano Genomics, distributed exclusively by Voden in Italy, for identification of structural variations (inversions, translocations, insertions, duplications, deletions) ranging from 500 bp to millions of bp in genetic disorders and cancer research.
- BioSkryb ResolveDNA / ResolveOME Single-Cell Analysis Single-cell genome and transcriptome analysis technology using Primary Template-directed Amplification (PTA) for whole genome/exome analysis with up to 97% genomic coverage, combined with whole transcriptome analysis.
- Immunogenetics and Transplant Biology Solutions HLA typing solutions using NGS, Sanger sequencing (SBTexcellerator, AlleleSeqr, SBTengine), and LinkSeq Real-Time PCR for complete HLA loci typing (A-B-C-DPB1-DQB1-DRB1-DRB3/4/5-DQA1-DPA1-G), KIR, MIC A/B, and chimerism monitoring (KMR qPCR); based on GenDx technology.
- Immunohematology Blood Group Typing Solutions Molecular analysis of erythrocyte and platelet antigens using LinkSeq Real-Time PCR for typing blood group systems (ABO, Rh, MNS, Kell, Duffy, Kidd, etc.) and HPA-1 to HPA-11, HPA-15, distributed in Italy by Voden.
- Oncohematology Cell Isolation Kits Cell isolation and enrichment kits for chronic lymphocytic leukemia (CLL) and multiple myeloma diagnostics, including RosetteSep and EasySep immunomagnetic separation systems.
- Automated Nucleic Acid Extraction Instruments Automated extraction instruments using magnetic ball technology with pre-aliquoted reagents in ready-to-use cartridges and built-in UV decontamination, scalable from different starting volumes for research laboratories.
- UVITEC Imaging Systems Cambridge-based imaging systems for chemiluminescence, epi-fluorescence (UV, RGB, NIR, IR), UV fluorescence, and cross-linker UV systems with CFR21-compliant analysis software for electrophoresis and imaging applications.
- StemCell Technologies Cell Culture Media Specialized and generic reagents for cell culture including stem cell media (pluripotent, mesenchymal, hematopoietic), specialized media for various tissue types, organoid cultures, and FBS sera; includes EasySep and RosetteSep cell separation systems and MethoCult media.
- VodenLink Professional Software Professional software platform for POCT instrument management enabling bi-directional communication with diagnostic analyzers, local and remote data management, and integration with hospital LIS/HIS systems.
- VodenLink PLUS Pharmacy Management Software Management software for pharmacy self-analysis areas connecting all diagnostic tools for automatic result transfer, patient record storage, and A4 report generation.
- RIQAS External Quality Assessment Service External Quality Assessment service in partnership with Randox providing quarterly whole-blood samples to Italian pharmacies for performance verification, statistical peer comparison, and ISO certification support.
Quantifiable outcome
- VChemy S provides up to 24 biochemical parameters from a single capillary blood sample with results in 12 minutes
- +3 more outcomes
Companies that use VODEN
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
VODEN technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability2 records
Feature6 records
VODEN partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered minor and core.
- SeegeneminorSouth Korean molecular diagnostics company Seegene has indicated its intention to enter the French market directly upon expiry of the distribution contract with Eurobio Scientific on 31 December 2026, with discussions ongoing regarding transition terms. Voden previously distributed Seegene products in Italy.
- Eurobio ScientificcoreEurobio Scientific acquired the life sciences unit of Voden Medical Instruments Spa in March 2025 as part of its acquisition strategy. This represents a significant partnership where Voden transitioned its life sciences distribution business to Eurobio Scientific, which reported 2025 annual revenue of €168 million with 9% growth driven by acquisitions including this life sciences unit.
- Bionano GenomicscoreVoden signed an exclusive distribution agreement for the whole Italian territory with Bionano Genomics company for optical genome mapping solutions using the Saphyr platform to detect structural variations in genetic disorders and cancer.
- UVITECcoreVoden signed exclusive distribution agreements with UVITEC, a Cambridge-based company founded in 1996 supplying cutting-edge documentation systems with unparalleled sensitivity and performance for electrophoresis and imaging applications.
- RandoxcoreVoden partnered with Randox, a leading company in the hospital quality sector, to offer the RIQAS external quality assessment service to Italian pharmacies. This partnership enables pharmacies to verify analytical performance and obtain ISO certification through quarterly whole blood sample testing and statistical comparison with peer pharmacies using the same instruments.
- GenDx (GenDx.com)coreVoden distributes GenDx products for immunogenetics and transplant biology including NGS-based HLA typing workflows, Sanger sequencing kits (SBTexcellerator, AlleleSeqr, SBTengine), and LinkSeq Real-Time PCR kits for HLA typing, KIR typing, and chimerism monitoring (KMR qPCR). GenDx reported €33.5 million revenue in 2025.
- SphingoteccoreVoden distributes Sphingotec's innovative biomarkers through the Nexus IB10 platform including penKid (for acute kidney injury prediction up to 2 days before serum creatinine), Bio-ADM (for endothelial barrier function and shock prediction), and DPP3 (for hemodynamic instability and mortality risk stratification) alongside established markers like PCT and D-Dimer.
- StemCell TechnologiescoreVoden distributes StemCell Technologies products in Italy including EasySep and RosetteSep cell separation systems, MethoCult media for hematopoietic stem cell colony assays, specialized cell culture media, and cytokine products for immunology research.
- Moelca srlcoreMoelca srl is the authorized technical assistance provider for Voden instruments, offering application technical support services to customers from their facility in Limido Comasco, CO. Provides remote assistance via Skype and on-site support.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
VODEN competitors and assessment
Company assessmentDirect peers
- DiaSorin: Italian-listed in vitro diagnostics company headquartered in Saluggia, Italy, with specialty immunoassay and molecular diagnostics offerings. Directly comparable as an Italian-headquartered diagnostics franchise operating in similar hospital and clinical lab channels.
- EKF Diagnostics: UK-based POCT manufacturer with point-of-care hemoglobin, HbA1c, and clinical chemistry analyzers plus central lab reagents. Comparable as a small-cap POCT-focused company distributing across European hospital and pharmacy channels.
- Trinity Biotech: Ireland-listed diagnostics company focused on point-of-care and clinical laboratory products, including hemoglobin A1c and infectious disease tests. Comparable as a small-mid cap POCT/diagnostics specialist competing in similar decentralized testing channels.
- Sentinel Diagnostics: Italian in vitro diagnostics manufacturer specializing in clinical chemistry, immunochemistry, and POCT reagents. Closely comparable as a domestic Italian IVD competitor serving the same hospital and pharmacy channels.
- QuidelOrtho: US-headquartered diagnostics company with a portfolio spanning rapid immunoassays, Sofia POCT, and specialty diagnostics. Comparable as a POCT-focused competitor with overlapping cardiac biomarker, infectious disease, and women's health test menus.
- Randox Laboratories: Northern Ireland-based diagnostics manufacturer with deep POCT and clinical chemistry menus. Randox is an existing Voden partnership counterparty (RIQAS external quality assessment in Italy), and competes directly with Voden's POCT and pharmacy self-analysis reagents.
Broad incumbents
- bioMérieux: French global in vitro and microbiology diagnostics leader with significant hospital, clinical lab, and industrial presence. Broadly comparable as a European specialty diagnostics platform competing for similar hospital procurement budgets.
- Werfen: Spanish-headquartered diagnostics company with strong hemostasis, acute care, and POCT franchises (including the GEM Premier blood gas platform that competes directly with Voden's OPTI CCA-TS2). Comparable as a European specialty POCT incumbent.
- Eurobio Scientific: French in vitro diagnostics distributor and parent company of Voden's life sciences unit (acquired March 2025). Listed on Euronext Growth Paris (ALERS) with €168M 2025 revenue and 42% of sales outside France; directly comparable as a European specialty diagnostics distributor covering similar clinical lab and hospital channels.
Emerging players
- HORIBA Medical: French-based hematology and clinical chemistry instrument manufacturer with a broad hospital lab and POCT footprint. Comparable as a European competitor offering overlapping hematology and clinical chemistry analyzer products to the same hospital and pharmacy end markets.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
VODEN compliance and trust
Trust signalCompliance2 records
VODEN financial estimates
Financial estimateRevenue estimate
Valuation estimate
VODEN leadership team
Management profileNumber of profiles
VODEN subsidiaries and ownership
Company hierarchySubsidiaries1 record
VODEN funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
VODEN M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about VODEN
What does VODEN do?
VODEN Medical Instruments S.p.A. manufactures and distributes point-of-care diagnostic instruments, reagents, and consumables across three divisions: POCT (hospital point-of-care testing for clinical chemistry, blood gas, hematology, cardiac biomarkers, and coagulation), Pharmacy (self-analysis diagnostic systems for Italian pharmacies under the Farmacia dei Servizi framework), and Life Science (immunogenetics, optical genome mapping, single-cell analysis, and cell biology research tools). The company also licenses the VodenLink software platform for instrument connectivity and LIS/HIS integration.
Is VODEN a public or private company?
VODEN is a private company. It is classified as corporate owned and is currently operating.
When was VODEN founded?
VODEN was founded in 2003. It employs 11 to 50 people.
Where is VODEN based?
VODEN is headquartered in Meda, Italy, in the Europe region.
How does VODEN make money?
Four revenue lines are on record. Diagnostic Instrument Sales are the primary driver. The others are reagent and Consumable Sales, software Licensing and technical Support and Service.
Who are VODEN's main competitors?
Direct peers on record are DiaSorin, EKF Diagnostics, Trinity Biotech, Sentinel Diagnostics, QuidelOrtho and Randox Laboratories. Broad incumbents are bioMérieux, Werfen and Eurobio Scientific. HORIBA Medical is listed as an emerging player.
Does VODEN have an API?
No public API is recorded for VODEN.
What industry is VODEN in?
VODEN's product category is Point-of-Care Diagnostics. Its primary akta.pro industry code is HLAHAOAC, Cardiac & Coagulation POCT (Troponin, BNP, INR/aPTT, D-dimer), with a secondary code of HLAHAOAD, Hematology POCT (CBC/hemoglobin/hematocrit). Its NAICS code is 334516 and its SIC code is 3826.